|
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents |
|
|
|
Titel: |
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents |
Auteur: |
Wils, Pauline Bouhnik, Yoram Michetti, Pierre Flourie, Bernard Brixi, Hedia Bourrier, Anne Allez, Matthieu Duclos, Bernard Grimaud, Jean-Charles Buisson, Anthony Amiot, Aurélien Fumery, Mathurin Roblin, Xavier Peyrin-Biroulet, Laurent Filippi, Jérôme Bouguen, Guillaume Abitbol, Vered Coffin, Benoit Simon, Marion Laharie, David Pariente, Benjamin |
Verschenen in: |
Clinical gastroenterology and hepatology |
Paginering: |
Jaargang 14 () nr. 2 pagina's 242-250.e2 |
Jaar: |
2016 |
Inhoud: |
|
Uitgever: |
AGA Institute |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|